Furthermore, SEPT9 methylation showed the best ability to discriminate between localised and metastasised disease detecting 18/23 CRC with distant metastases in our cohort (78.3%, AUC = 0.79, [95% CI 0.69–0.89], Fig. 3a). This evidence concerns the gene SEPTIN9 and colorectal carcinoma.